Sandbox:Nasrin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
---- | ---- | ||
{{familytree/start}} | |||
{{familytree/start}}{{familytree | | | | | | | | | A01 | | | | | |A01= [[COVID-19]] }} | |||
{{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }} | {{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }} | ||
{{familytree | | C01 | | | | | | | | | | | | C02 |C01= '''30-40%''' <br> [[Asymptomatic]]|C02= '''60-70%''' <br> [[Symptomatic]]}} | {{familytree | | C01 | | | | | | | | | | | | C02 |C01= '''30-40%''' <br> [[Asymptomatic]]|C02= '''60-70%''' <br> [[Symptomatic]]}} | ||
Revision as of 09:17, 12 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
| COVID-19 | |||||||||||||||||||||||||||||||||||||||||||||||
| 30-40% Asymptomatic | 60-70% Symptomatic | ||||||||||||||||||||||||||||||||||||||||||||||
| Asymptomatic carrier | 80% Mild symtoms | 14% Severe symptoms | 6% Critically ill | ||||||||||||||||||||||||||||||||||||||||||||
| Fever Chills Cough Headache Sore throat Nasal congestion or secretion Fatigue Body aches loss of taste or smell Nausea or vomiting Diarrhea | Severe Dyspnea Chest pain Severe weakness new Confusion Central Cyanosis | Death | |||||||||||||||||||||||||||||||||||||||||||||